Rolling Action Plan (RAP) for UK REACH 2025, 2026 and 2027

1. In accordance with Article 44 of UK REACH and the criteria outlined in the "Approach to substance evaluation in UK REACH", the UK rolling action plan (RAP) is updated as shown in table 1.
2. Our approach to substance selection seeks to complement rather than replicate evaluation work that has been or will be performed by other regulatory regimes (such as via EU REACH) and avoid unnecessary duplication of work where testing is indicated as the outcome of evaluation.
3. The selection of substances for inclusion in the RAP is based on the hazard profile of substances and their exposure potential in GB, including consideration of the quantities supplied. We consider information from the following sources to identify priorities:
   • the GB specific registration data, where available, within the UK database (Comply with UK REACH)
   • UK REACH processes (such as dossier evaluation)
   • Other intelligence such as the Environment Agency’s Prioritisation and Early Warning System (PEWS) and horizon scanning of other regulatory regimes, both domestic (e.g., GB CLP) and international (e.g., EU REACH and positions on chemicals adopted by other countries) 
4. Substances that are registered under UK REACH can be prioritised for evaluation where a potential concern has been identified (such as where there are grounds for considering that a substance constitutes a risk to human health or the environment). An evaluation will determine if a conclusion on the concern can be drawn from the available data. If a conclusion cannot be drawn, we can as the Agency for UK REACH, request that registrants provide additional information. In such cases, deadlines will be set by which the information shall be provided. A substance will only be included in the RAP where a request for further information from the UK registrants may help to clarify the concern.
5. Using the sources referred to in paragraph 3, along with the criteria referred to in paragraph 1, the Agency has not identified any priorities to take forward for formal substance evaluation under UK REACH in 2025. However, we will continue to consider the information available to us to define future priorities.

Table 1: RAP for UK REACH 2025-27